Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Gastric cancer
ADR ID BADD_A01723
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.13      Gastrointestinal neoplasms malignant and unspecified
16.13.03      Gastric neoplasms malignant
16.13.03.001      Gastric cancer
07      Gastrointestinal disorders
07.21      Malignant and unspecified neoplasms gastrointestinal NEC
07.21.02      Gastric neoplasms malignant
07.21.02.001      Gastric cancer
Description Tumors or cancer of the STOMACH. [MeSH]
MedDRA Code 10017758
MeSH ID D013274
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Antral carcinoma | Carcinoma gastric | Carcinoma stomach | Gastric cancer | Gastric cancer NOS | Gastric carcinoma | Gastric malignancy | Malignant neoplasm of body of stomach | Malignant neoplasm of cardia | Malignant neoplasm of fundus of stomach | Malignant neoplasm of greater curvature of stomach, unspecified | Malignant neoplasm of lesser curvature of stomach, unspecified | Malignant neoplasm of other specified sites of stomach | Malignant neoplasm of pyloric antrum | Malignant neoplasm of pylorus | Malignant neoplasm of stomach | Malignant neoplasm of stomach, unspecified | Pyloric carcinoma | Scirrhous gastric carcinoma | Stomach cancer | Stomach carcinoma | Advanced gastric carcinoma | Stomach Neoplasms | Neoplasm, Stomach | Stomach Neoplasm | Neoplasms, Stomach | Gastric Neoplasms | Gastric Neoplasm | Neoplasm, Gastric | Neoplasms, Gastric | Cancer of Stomach | Stomach Cancers | Gastric Cancer | Cancer, Gastric | Cancers, Gastric | Gastric Cancers | Stomach Cancer | Cancer, Stomach | Cancers, Stomach | Cancer of the Stomach | Gastric Cancer, Familial Diffuse
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01245Lansoprazole0.000199%
BADD_D01247Lanthanum carbonate0.001239%
BADD_D01253Lenalidomide--
BADD_D01260Leuprolide acetate--
BADD_D01566Nifedipine0.000075%
BADD_D01567Nilotinib0.000560%
BADD_D01601Olaparib0.000224%
BADD_D01614Omeprazole0.000047%
BADD_D01653Paclitaxel0.000560%
BADD_D01817Pramipexole--
BADD_D01818Pramipexole dihydrochloride--
BADD_D01898Rabeprazole0.000391%
BADD_D01903Raloxifene0.000226%
BADD_D01913Ranitidine0.010593%
BADD_D01966Ropinirole--
BADD_D01973Rotigotine0.000367%
BADD_D02006Selexipag0.000082%
BADD_D02029Sitagliptin0.000159%
BADD_D02043Sodium iodide i-131--
BADD_D02053Sofosbuvir0.000847%
BADD_D02100Sunitinib0.000996%
BADD_D02214Ticagrelor0.000408%
BADD_D02237Tofacitinib citrate--
BADD_D02246Tolvaptan0.000058%
BADD_D02252Tositumomab--
BADD_D02277Triazolam0.000403%
BADD_D02325Valdecoxib--
BADD_D02331Valsartan0.000582%
BADD_D02375Water--
BADD_D02392Zoledronic acid--
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages